Global Patent Index - EP 0968432 A1

EP 0968432 A1 2000-01-05 - GROWTH FACTOR-DEPENDENT DISEASES

Title (en)

GROWTH FACTOR-DEPENDENT DISEASES

Title (de)

WACHSTUMSFAKTORABHÄNGIGE KRANKHEITEN

Title (fr)

MALADIES LIEES AU FACTEUR DE CROISSANCE

Publication

EP 0968432 A1 (EN)

Application

EP 98900887 A

Priority

  • GB 9800033 W
  • GB 9700933 A

Abstract (en)

[origin: WO9832022A1] A method of identifying or developing a compound which is useful in treating a growth factor-dependent disease, the method comprising the step of determining whether the compound modulates the amount, function or structural integrity of a growth factor binding protein.

IPC 1-7 (main, further and additional classification)

G01N 33/74; A61K 45/00; G01N 33/574

IPC 8 full level (invention and additional information)

G01N 33/50 (2006.01); A61K 31/401 (2006.01); A61K 38/00 (2006.01); A61K 45/00 (2006.01); A61P 19/10 (2006.01); A61P 35/00 (2006.01); A61P 43/00 (2006.01); G01N 33/15 (2006.01); G01N 33/53 (2006.01); G01N 33/566 (2006.01); G01N 33/573 (2006.01); G01N 33/574 (2006.01); G01N 33/74 (2006.01)

CPC (invention and additional information)

G01N 33/57434 (2013.01); G01N 33/74 (2013.01)

Citation (search report)

See references of WO 9832022A1

Designated contracting state (EPC)

GB

EPO simple patent family

WO 9832022 A1 19980723; EP 0968432 A1 20000105; GB 9700933 D0 19970305; JP 2001511783 A 20010814

INPADOC legal status


2001-10-10 [18D] DEEMED TO BE WITHDRAWN

- Effective date: 20010403

2000-11-08 [17Q] FIRST EXAMINATION REPORT

- Effective date: 20000921

2000-06-07 [RAP1] TRANSFER OF RIGHTS OF AN EP PUBLISHED APPLICATION

- Owner name: NATIONAL CANCER CENTRE OF SINGAPORE PTE LIMITED

2000-01-05 [17P] REQUEST FOR EXAMINATION FILED

- Effective date: 19990813

2000-01-05 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A1

- Designated State(s): GB